$CVEO

Civeo Corp

AlphAI earnings readsecond quarter 2026 · JUL 30Civeo Reports Second Quarter 2026 ResultsVerdict: mixed

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

No enriched coverage for $CVEO in the last 7 days.

No SEC Form 4 filings for $CVEO in the last 30 days.

See all $CVEO insider activity →
Low

Northland initiates Civeo stock with Outperform rating on infrastructure demand

Northland initiated Civeo Corp. (NYSE:CVEO) with an Outperform rating and $42 price target, citing strong infrastructure demand and undervaluation. The company's stock has risen 43% YTD. Civeo reported Q2 2026 earnings beating estimates, with revenue of $180M. Multiple analysts have rated the stock positively with varying price targets.

Roth/MKM initiates Civeo stock with buy rating on valuation gap

Roth/MKM initiated coverage on Civeo Corporation (NYSE:CVEO) with a buy rating and a $39.00 price target, citing undervaluation and strong growth prospects. The company's stock is up 43% year-to-date, and it recently reported better-than-expected Q2 2026 earnings. Multiple analysts have expressed confidence in Civeo's future performance, with Stifel and Raymond James also issuing positive ratings.

CVEO sentiment & insider activity

Recent CVEO coverage spans earnings, financial news and insider activity.

What's driving CVEO

AlphAI scores every news story that mentions CVEO with an AI model for sentiment and relevance, and aggregates insider trades from Civeo Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $CVEO

Score

Roth/MKM initiates Civeo stock with buy rating on valuation gap

Roth/MKM initiated coverage on Civeo Corporation (NYSE:CVEO) with a buy rating and a $39.00 price target, citing undervaluation and strong growth prospects. The company's stock is up 43% year-to-date, and it recently reported better-than-expected Q2 2026 earnings. Multiple analysts have expressed confidence in Civeo's future performance, with Stifel and Raymond James also issuing positive ratings.

$BMYMed

Best Buy downgraded, Bristol Myers upgraded: Wall Street's top analyst calls

Analyst actions highlighted: Argus upgraded Bristol Myers (BMY) to Buy, $75 target, citing margin improvement and raised 2026 guidance. Freedom Broker upgraded McDonald's (MCD) to Buy, $305 target, on softer revenue and comps. Morgan Stanley upgraded Humana (HUM) to Equal Weight, $370 target. Jefferies downgraded Best Buy (BBY) to Hold, $85 target. Others included upgrades/downgrades for several stocks with updated price targets.

Med

Civeo Corporation Q2 2026 Earnings Call Summary

Civeo Corporation reported Q2 2026 earnings call updates. Management cited a $1.5 billion North America contract pipeline, resilient Australian metallurgical coal prices above $220/tonne, and a July 2026 convertible debt offering to reduce capital costs and fund mobilizations. Full-year 2026 guidance was unchanged, with Canada projected for 20% H2 revenue growth and a capital return target of at least 75% of free cash flow.

$CVEOLow

Civeo (CVEO) Stock Faces Margin Squeeze Despite Higher Revenue

Simply Wall St reports Civeo (NYSE:CVEO) shares fell about 1.6% after Q2 2026 revenue rose to about $180m (up 10.7% YoY). Adjusted EBITDA was near $23.8m, but net loss was about $2.5m. Adjusted EBITDA margin compressed to ~13.2%. 2026 guidance remains $675m-$700m revenue and $85m-$90m adjusted EBITDA.

$CVEOMedAI 8/10

Civeo (CVEO) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 9:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Bradley Dodson Chief Financial Officer and Treasurer - Collin Gerry Vice President, Corporate Development - Regan Nielsen TAKEAWAYS Total Revenue -- $180 million, representing an 11% increase from $162.7 million in the prior year period. Net Loss -- $2.5 million, compared to a net loss of $3.3 million in the second quarter of 2025.

$CVEOMed

Civeo Reports Second Quarter 2026 Results

Civeo Corp (CVEO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Civeo Reports Second Quarter 2026 Results Highlights: • Reported revenues of $180.0 million, net loss of $2.5 million and Adjusted EBITDA of $23.8 million; • Consolidated revenues increased 11%, driven by integrated services growth in both Australia and Canada, higher occupancy i

Related tickers